SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-106146
Filing Date
2023-10-03
Accepted
2023-10-03 07:35:54
Documents
20
Period of Report
2023-10-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2327397d1_8k.htm   iXBRL 8-K 52376
2 EXHIBIT 2.1 tm2327397d1_ex2-1.htm EX-2.1 529721
3 EXHIBIT 99.1 tm2327397d1_ex99-1.htm EX-99.1 88685
4 EXHIBIT 99.2 tm2327397d1_ex99-2.htm EX-99.2 91175
5 EXHIBIT 99.3 tm2327397d1_ex99-3.htm EX-99.3 90547
6 EXHIBIT 99.4 tm2327397d1_ex99-4.htm EX-99.4 22745
10 GRAPHIC tm2327397d1_ex99-4img001.jpg GRAPHIC 3915
11 GRAPHIC tm2327397d1_ex99-4img002.jpg GRAPHIC 10865
12 GRAPHIC tm2327397d1_ex99-4img003.jpg GRAPHIC 12161
  Complete submission text file 0001104659-23-106146.txt   1296846

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA pnt-20231002.xsd EX-101.SCH 3030
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE pnt-20231002_lab.xml EX-101.LAB 34240
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pnt-20231002_pre.xml EX-101.PRE 22370
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2327397d1_8k_htm.xml XML 3318
Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (317) 543-9957
POINT Biopharma Global Inc. (Filer) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39373 | Film No.: 231301561
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences